SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001808805-23-000064
Filing Date
2023-06-16
Accepted
2023-06-16 20:07:02
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168696040915626.html 4  
1 FORM 4 wf-form4_168696040915626.xml 4 4206
  Complete submission text file 0001808805-23-000064.txt   5636
Mailing Address 1000 SECOND AVENUE SUITE 3700 SEATTLE WA 98104
Business Address
McIlwain Matthew S (Reporting) CIK: 0001381752 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39434 | Film No.: 231022989

Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

IRS No.: 981541723 | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments